Thein Tut

Dr. Thein Tut

orcid

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

1 June 1999 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
FGFarid J. Ghadessy
Farid J. Ghadessy
JLJoyce Lim
Joyce Lim
AAAbdullah A.R. Abdullah
Abdullah A.R. Abdullah
VPValerie Panet-Raymond
Valerie Panet-Raymond
CCChee Keong Choo
Chee Keong Choo
EYEu-Leong Yong
Eu-Leong Yong
Structural changes in the androgen receptor (AR) are one of the causes of defective spermatogenesis. We screened the AR gene of 173 infertile men with impaired spermatogenesis and identified 3 of them, unrelated, who each had a single adenine→guanine transition that changed codon 886 in exon 8 from methionine to valine. This mutation was significantly associated with the severely oligospermic phenotype and was not detected in 400 control AR alleles. Despite the location of this substitution in the ligand-binding domain (LBD) of the AR, neither the genital skin fibroblasts of the subjects nor transfected cell types expressing the mutant receptor had any androgen-binding abnormality. However, the mutant receptor had a consistently (approximately 50%) reduced capacity to transactivate each of 2 different androgen-inducible reporter genes in 3 different cell lines. Deficient transactivation correlated with reduced binding of mutant AR complexes to androgen response elements. Coexpression of AR domain fragments in mammalian and yeast two-hybrid studies suggests that the mutation disrupts interactions of the LBD with another LBD, with the NH2-terminal transactivation domain, and with the transcriptional intermediary factor TIF2. These data suggest that a functional element centered around M886 has a role, not for ligand binding, but for interdomain and coactivator interactions culminating in the formation of a normal transcription complex. J. Clin. Invest. 103:1517–1525 (1999).

5 June 2015 in PLOS ONE
Verified
Journal Article
Open access
PDF file
TTThein Tut
Thein Tut
SLStephanie Lim
Stephanie Lim
IDI. U. Dissanayake
I. U. Dissanayake
JDJ. Descallar
J. Descallar
WCW. Chua
W. Chua
C. Soon LeeC. Soon Lee
C. Soon Lee
Human polo-like kinase 1 (PLK1) expression has been associated with inferior outcomes in colorectal cancer. Our aims were to analyse PLK1 in rectal cancer, and its association with clinicopathological variables, overall survival as well as tumour regression to neoadjuvant treatment. PLK1 expression was quantified with immunohistochemistry in the centre and periphery (invasive front) of rectal cancers, as well as in the involved regional lymph nodes from 286 patients. Scores were based on staining intensity and percentage of positive cells, multiplied to give weighted scores from 1–12, dichotomised into low (0–5) or high (6–12). PLK1 scores in the tumour periphery were significantly different to adjacent normal mucosa. Survival analysis revealed that low PLK1 score in the tumour periphery had a hazard ratio of death of 0.59 in multivariate analysis. Other predictors of survival included age, tumour depth, metastatic status, vascular and perineural invasion and adjuvant chemotherapy. There was no statistically significant correlation between PLK1 score and histological tumour regression in the neoadjuvant cohort. Low PLK1 score was an independent predictor of superior overall survival, adjusting for multiple clinicopathological variables including treatment.

1 January 2013 in The Korean Journal of Pathology
Verified
Journal Article
Open access
PDF file
JSJoo-Shik Shin
Joo-Shik Shin
TTThein Tut
Thein Tut
TYTao Yang
Tao Yang
C. Soon LeeC. Soon Lee
C. Soon Lee
Shin JS, et al. Korean J Pathol. 2013 Feb;47(1):1-8. http://dx.doi.org/10.4132/KoreanJPathol.2013.47.1.1

8 December 2016 in PLOS ONE
Verified
Journal Article
Open access
PDF file
Vincent HoVincent Ho
Vincent Ho
LCLiping Chung
Liping Chung
MRMaxine Revoltar
Maxine Revoltar
SLStephanie H Lim
Stephanie H Lim
TTThein Tut
Thein Tut
JSJoo-Shik Shin
Joo-Shik Shin
Aberrant expression of DNA repair proteins is associated with poor survival in cancer patients. We investigated the combined expression of MRE11 and ATM as a predictive marker of response to radiotherapy in rectal cancer. MRE11 and ATM expression were examined in tumor samples from 262 rectal cancer patients who underwent surgery for rectal cancer, including a sub-cohort of 54 patients who were treated with neoadjuvant radiotherapy. The relationship between expression of the two-protein panel and tumor regression grade (TRG) was assessed by Mann–Whitney U test and receiver operating characteristics area under curve (ROC-AUC) analysis. The association between expression of the two-protein panel and clinicopathologic variables and survival was examined by Kaplan-Meier methods and Cox regression analysis. A high score for two-protein combined expression in the tumor center (TC) was significantly associated with worse disease-free survival (DFS) (P = 0.035) and overall survival (OS) (P = 0.003) in the whole cohort, and with DFS (P = 0.028) and OS (P = 0.024) in the neoadjuvant subgroup (n = 54). In multivariate analysis, the two-protein combination panel (HR = 2.178, 95% CI 1.115–4.256, P = 0.023) and perineural invasion (HR = 2.183, 95% CI 1.222–3.899, P = 0.008) were significantly associated with DFS. Using ROC-AUC analysis of good versus poor histological tumor response among patients treated preoperatively with radiotherapy, the average ROC-AUC was 0.745 for the combined panel, 0.618 for ATM alone, and 0.711 for MRE11 alone. The MRE11/ATM two-protein panel developed in this study may have clinical value as a predictive marker of tumor response to neoadjuvant radiotherapy, and a prognostic marker for disease-free and overall survival.

13 February 1998 in Molecular and Cellular Endocrinology
Verified
Journal Article
Closed access
EYEu-Leong Yong
Eu-Leong Yong
TTThein Tut
Thein Tut
FGF J Ghadessy
F J Ghadessy
GPG Prins
G Prins
SRS S Ratnam
S S Ratnam